Sodium–Glucose Cotransporter 2 Inhibitors and Euglycemic Diabetic Ketoacidosis: Metabolic Acidosis With a Twist

Eitemau Tebyg

• Euglycemic diabetic ketoacidosis associated with the use of a sodium–glucose cotransporter-2 inhibitor
  gan: Zhang, Lydia, et al.
  Cyhoeddwyd: (2018)
• Euglycemic Diabetic Ketoacidosis With Prolonged Glucosuria Associated With the Sodium-Glucose Cotransporter-2 Canagliflozin
  gan: Kelmenson, Daniel A., et al.
  Cyhoeddwyd: (2017)
• Euglycemic diabetic ketoacidosis in type 2 diabetes treated with a sodium-glucose cotransporter-2 inhibitor
  gan: Jazi, Mazen, et al.
  Cyhoeddwyd: (2016)
• Prolonged euglycemic diabetic ketoacidosis triggered by a single dose of sodium–glucose cotransporter 2 inhibitor
  gan: Miwa, Maki, et al.
  Cyhoeddwyd: (2020)
• Periprocedural Euglycemic Diabetic Ketoacidosis Associated With Sodium–Glucose Cotransporter 2 Inhibitor Therapy During Colonoscopy
  gan: Meyer, Emily J., et al.
  Cyhoeddwyd: (2020)